May 2 (Reuters) - Immutep Ltd (IMM) : POSITIVE INITIAL CLINICAL...

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    May 2 (Reuters) - Immutep Ltd (IMM) :

    • POSITIVE INITIAL CLINICAL DATA REPORTED FROM IMMUTEP’S EFTI COMBINED WITH RADIOTHERAPY AND CHECKPOINT INHIBITOR FROM PHASE II TRIAL IN SOFT TISSUE SARCOMA
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
24.0¢
Change
0.005(2.13%)
Mkt cap ! $352.2M
Open High Low Value Volume
23.5¢ 24.0¢ 23.0¢ $290.4K 1.234M

Buyers (Bids)

No. Vol. Price($)
1 20323 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 138776 4
View Market Depth
Last trade - 16.10pm 11/09/2025 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.